Abstract
Purpose of the ReviewThe purpose of this review is to address the rising incidence of cerebral metastases in breast cancer patients, which is now estimated to affect 30–40% of advanced breast cancer (ABC) patients.Recent FindingsMagnetic resonance imaging (MRI) remains the gold standard for brain metastases (BM) diagnosis, with follow-up scans recommended every 3 months. Treatment options for BM include neurosurgery, stereotactic radiosurgery (SRS), stereotactic fractionated radiation therapy (SFRT), or whole brain radiation therapy (WBRT), selected based on BM number, size, and location. Local therapies like SRS or neurosurgery are preferred for single or oligo metastases, while SRS or WBRT may be used for multiple BM. Concurrent systemic treatment tailored to tumor biology is crucial, particularly with recent advancements in HER2-positive patient management..SummarySymptomatic BM warrants local treatment alongside systemic therapy, considering patient condition and prognosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
